Newlink Genetics reported $-7251000 in Pre-Tax Profit for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Pre Tax Profit Change
Agenus AGEN:US USD -56715000 7.48M
Capricor Therapeutics CAPR:US USD -6371000 738K
Celldex Therapeutics CLDX:US USD -26784000 546K
Idera Pharmaceuticals IDRA:US USD 9.14M 14.44M
Intrexon XON:US USD -7694000 18.45M
Nektar Therapeutics NKTR:US USD -59204000 99.76M
Newlink Genetics NLNK:US USD -7251000 593K
Pfizer PFE:US USD 10.67B 3.11B
Prothena PRTA:US USD -48417000 5.84M
Sarepta Therapeutics SRPT:US USD -256418000 28.32M
Vascular Biogenics VBLT:US USD -9170000 264K
YTE INCY:US USD 178.22M 131.36M